NEWS

LATEST TROPIQ NEWS

TropIQ team contributes to study on Plasmodium kinase inhibitor

The publication "Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase." came out today ...
Read more
/ News

TropIQ receives price for Dutch innovative startup

TropIQ receives the Unilever Sustainable Innovation Prize for the Dutch innovative startup best contributing to the Sustainable Development Goals as put forward by the United Nations ...
Read more
/ News

TropIQ is awarded with a ‘Pearl of the region’

TropIQ is awarded with a 'Pearl of the region' award by The Economic Board. Waarom roept The Economic Board ‘parels van de regio’ in het leven? De Board communiceert over ...
Read more
/ News

TropIQ staff co-authors paper in Nature

Nature publishes the paper 'Diversity-oriented synthesis yields novel multistage antimalarial inhibitors' that is co-authored by TropIQ staff. Antimalarial drugs have thus far beenchiefly derived from two sources—natural products and synthetic ...
Read more
/ News

Malaria Journal publishes our newest paper ” An inter-laboratory comparison of the Standard Membrane Feeding Assay”

Here the "gold standard" status for transmission blocking activity of antibodies, the standard membrane feeding assay (SMFA), is verified in two different laboratories. Read the article here. ...
Read more
/ News

TropIQ moves to different location

TropIQ has moved to a brand new laboratory at the Noviotech campus in Nijmegen, The Netherlands ...
Read more
/ News

TropIQ enters consortium

TropIQ has entered a Netherlands-based consortium that teams up with MMV in world-leading malaria translational research ...
Read more
/ News

TropIQ enters partnership

TropIQ enters partnership with MMV (Medicines for Malaria Venture) on generation of a pantothenamide clinical candidate ...
Read more
/ News

Scientific Reports publishes our paper

"A semi-automated luminescence based standard membrane feeding assay identifies novel small molecules that inhibit transmission of malaria parasites by mosquitoes" We describe here for the first time a standard membrane ...
Read more
/ News

TropIQ receives research grant

TropIQ receives a Grand Challenges and Explorations award from the Bill & Melinda Gates Foundation to develop barcoded insect screens for optimization of artificial diets ...
Read more
/ News

TropIQ co-authors Scientific Report publication

TropIQ staff co-authors the study 'A simple and predictive phenotypic High Content Imaging assay for Plasmodium falciparum mature gametocytes to identify malaria transmission blocking compounds' that was published by Scientific Reports today ...
Read more
/ News

TropIQ employees co-author published study

TropIQ employees co-author the study 'A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria' that was published by Science Translational Medicine today ...
Read more
/ News

TropIQ contribute to vaccine cocktail study

TropIQ contributed to the study 'Analysis of a Multi-component Multi-stage Malaria Vaccine Candidate—Tackling the Cocktail Challenge' that was published by Plos One today ...
Read more
/ News

Co-authorship in Nature publication

Nature publishes the paper 'A novel multiple-stage antimalarial agent that inhibits protein synthesis' that is co-authored by TropIQ ...
Read more
/ News

TropIQ employees co-author publication

TropIQ employees co-author the manuscript 'Salinomycin and other ionophores as new class of antimalarial drugs with transmission blocking activity' that appeared in Antimicrobial Agents and Chemotherapy today ...
Read more
/ News

TropIQ co-authors manuscript

TropIQ employees co-author the manuscript Novel pantothenate derivatives for anti-malarial chemotherapy that appeared in Malaria Journal today ...
Read more
/ News

TropIQ publishes validation of transmission assay

In the publication "A combination of new screening assays for prioritization of transmission-blocking antimalarials ...
Read more
/ News

TropIQ enters partnership with Calibr

TropIQ and the California Research Institute for Biomedical Research (Calibr) enter a research collaboration. TropIQ will perform barcoded mosquito assay to support Calibr's insecticide program ...
Read more
/ News